Chief Financial Officer
Marina D’Emic is Chief Financial Officer of the Alzheimer’s Drug Discovery Foundation (ADDF), where she leads the finance function, including accounting, financial planning, and operations. As a trusted advisor to executive leadership and the Board, she shapes the financial strategy that supports the ADDF’s mission and long-term sustainability.
She joined the ADDF in 2021 and was promoted to CFO in 2026. With nearly 20 years of nonprofit and corporate finance experience, including positions at Publicis Groupe, Interbrand, and Dentsu Aegis, Marina is known for strengthening financial reporting and translating complex financial information into clear insight for decision-making. A growing focus of her work is the application of technology and artificial intelligence to financial operations. Marina is leading the ADDF’s effort to implement AI-enabled tools that improve efficiency, deepen analysis, and support better decision-making.
A Certified Public Accountant licensed in New York, Marina is a graduate of Baruch College’s Zicklin School of Business, where she earned her BBA in Accounting. She also serves on the board of the Greenbelt Conservancy.